ARS clinical operations team has successfully completed a series of bioequivalence clinical trial projects (Levofloxacin, Imatinib, Irbesartan, Linezolid, Abacavir, Abacavir + Lamivudine, Emtricitabine + Tenofovir, Valganciclovir) for three leading Indian pharmaceutical companies. The studies were performed within drug registration procedure in Russia. Statistical analysis and final clinical study reports are in preparation now.